TY  - JOUR
AU  - Mahanty, S
AU  - Prigent, A
AU  - Garraud, O
Y2  - 2020/12/18
Y1  - 2015/05/29
SN  - 1471-2172
UR  - http://hdl.handle.net/11343/255833
AB  - The concept of the immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. However, the theoretical notion of immunogenicity as discussed in older textbooks of immunology needs reconsideration due to advances in our understanding of immunologic responses. Immunogenicity is a property that can either be a desirable attribute, for example in the generation of an effective protective immunity against infectious pathogens or an undesirable trait, for example when it relates to novel therapeutic compounds and drugs, where an immune response needs to be prevented or inhibited. In this Forum Article, we aimed to revisit the issue of immunogenicity to discuss a series of simple questions relevant to the concept that are frequently rephrased but incompletely resolved in the immunologic literature.
LA  - English
PB  - BMC
T1  - Immunogenicity of infectious pathogens and vaccine antigens
DO  - 10.1186/s12865-015-0095-y
IS  - BMC Immunology
VL  - 16
IS  - 1
L1  - /bitstream/handle/11343/255833/PMC4446803.pdf?sequence=1&isAllowed=y
ER  -